SCHEMBL7230332

SCHEMBL7230332

CC(O)(I)c1cccc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 4/20 0.48
ACHE P22303 2/20 0.46
CYP19A1 P11511 2/20 0.44
CHRM3 P20309 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MDM4 O15151 1/20 0.39
TP53 P04637 1/20 0.39
MDM2 Q00987 1/20 0.39
PTPN1 P18031 1/20 0.38
KIF11 P52732 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NFE2L2 Q16236 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24824473 0.83 KCNN4 (0.52) KCNN4ACHECYP19A1CHRM3HDAC3
SCHEMBL22012213 0.83 KCNN4 (0.52) KCNN4ACHECYP19A1CHRM3HDAC3
SCHEMBL25134588 0.80 KCNN4 (0.48) KCNN4ACHECYP19A1CHRM3HDAC3
SCHEMBL26687550 0.79 KCNN4 (0.48) KCNN4ACHECYP19A1CHRM3HDAC3
SCHEMBL2635547 0.79 CES2 (0.47) TP53CES2ALDH1A1POLBGAA
SCHEMBL3346352 0.79 CES2 (0.47) TP53CES2ALDH1A1POLBGAA
SCHEMBL27918654 0.79 KCNN4 (0.48) KCNN4ACHECYP19A1CHRM3HDAC3
SCHEMBL7929172 0.78 KCNN4 (0.50) KCNN4ACHECYP19A1CHRM3HDAC3
SCHEMBL179310 0.78 KCNN4 (0.50) KCNN4ACHECYP19A1HDAC3HDAC1
SCHEMBL11597249 0.78 KCNN4 (0.55) KCNN4ACHECYP19A1CHRM3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030064991-A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030064991-A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor ACKR3, CCR5, CXCR4 KCNN4 4467/4885ACHE 2842/4885CYP19A1 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.